NCT03382119

Brief Summary

The goal of this study is to determine if ultrasound tools can be used to detect liver stiffness. Acoustic radiation force impulse (ARFI) elastography and backscatter will be used to see if they can detect liver stiffness in different populations of patients with liver disease. The study is measuring liver stiffness in pediatric patients aged 2-5 years. Patients either have had a Fontan cardiac surgery or have liver disease. Ultrasound scanning takes images of the liver and has much lower risks for patients. ARFI elastography and other tools can be used to measure liver stiffness.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Apr 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 13, 2017

Completed
9 days until next milestone

First Posted

Study publicly available on registry

December 22, 2017

Completed
4 months until next milestone

Study Start

First participant enrolled

April 11, 2018

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 19, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 19, 2019

Completed
Last Updated

June 2, 2020

Status Verified

May 1, 2020

Enrollment Period

1.3 years

First QC Date

December 13, 2017

Last Update Submit

May 29, 2020

Conditions

Keywords

liver stiffness Fontan

Outcome Measures

Primary Outcomes (1)

  • Shear wave speed

    Shear wave speed is a measure of stiffness of liver tissue expressed in units of m/s

    15 minutes

Study Arms (2)

Patients having Fontan cardiac surgery

This group includes pediatric patients, aged 2-5 years, who have had a Fontan operation. This surgery corrects a heart defect found at birth in which the heart has only one ventricle. Patients will have an Ultrasound with ARFI imaging.

Device: Ultrasound with ARFI (acoustic radiation force impulse)Device: Ultrasound with backscatter imaging

Patients with Liver disease

This group includes pediatric patients, aged 2-5 years, who have chronic liver disease caused by biliary atresia. Patients will have an Ultrasound with ARFI imaging.

Device: Ultrasound with ARFI (acoustic radiation force impulse)Device: Ultrasound with backscatter imaging

Interventions

This technology uses sound waves to measure the stiffness of tissue.

Also known as: elastography
Patients having Fontan cardiac surgeryPatients with Liver disease

This ultrasound tool gathers data from the waves returning from imaged tissue.

Patients having Fontan cardiac surgeryPatients with Liver disease

Eligibility Criteria

Age2 Years - 5 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Patients will either be scheduled for a Stage 3 Fontan cardiac operation or have chronic liver disease caused by biliary atresia.

You may qualify if:

  • Patients aged 2-5 years
  • Children who are scheduled to have a Stage 3 Fontan cardiac operation (arm 1) AND Children who have chronic liver disease caused by biliary atresia (arm 2)
  • Patient must be receiving care at the University of Michigan CS Mott Children's Hospital
  • Parent/guardian must be willing to sign the study consent form

You may not qualify if:

  • For arm 1 subjects: pre-existing evidence of chronic liver disease (as defined by chronic elevation (over 4 weeks) of alanine aminotransferase (ALT), aspartate aminotransferase (AST), or conjugated bilirubin to greater than two times the upper limit of normal
  • For arm 1 subjects: evidence of overt liver nodularity by conventional US imaging or evidence of portal vein or hepatic vein thrombosis (clots) by US Doppler exam

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

C.S. Mott Hospital

Ann Arbor, Michigan, 48109, United States

Location

MeSH Terms

Conditions

Liver Cirrhosis

Interventions

UltrasonographyElasticity Imaging Techniques

Condition Hierarchy (Ancestors)

Liver DiseasesDigestive System DiseasesFibrosisPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Diagnostic ImagingDiagnostic Techniques and ProceduresDiagnosis

Study Officials

  • Frank DiPaola, MD

    University of Michigan

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

December 13, 2017

First Posted

December 22, 2017

Study Start

April 11, 2018

Primary Completion

July 19, 2019

Study Completion

July 19, 2019

Last Updated

June 2, 2020

Record last verified: 2020-05

Data Sharing

IPD Sharing
Will not share

Locations